In addition, in NAFLD mouse models and patients, the aggregation of OSBPL3-related inflammation and fibrogenesis indicates that the LRH-1-OSBPL3 signal may trigger the pathogenesis of NASH [201,203,204]. The gene discussed is NR5A2; the disease is metabolic dysfunction-associated steatotic liver disease.